Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and bay 41-8543

quinoxalines has been researched along with bay 41-8543 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, P; Schramm, M; Schröder, H; Stasch, JP1
Bellas, E; Bloch, KD; Buys, ES; Evgenov, NV; Evgenov, OV; Gnoth, MJ; Graveline, AR; Hess, DR; Kohane, DS; Langer, R; Liu, R; Stasch, JP; Volpato, GP; Zapol, WM1
Buck, J; Hess, KC; Levin, LR; Ramos-Espiritu, LS1
Fernández-Fernández, D; Kroker, KS; Rosenbrock, H1

Other Studies

4 other study(ies) available for quinoxalines and bay 41-8543

ArticleYear
Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.
    European journal of pharmacology, 2003, May-16, Volume: 468, Issue:3

    Topics: Benzoates; Diethylamines; Enzyme Activation; Guanylate Cyclase; Heme; Morpholines; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Oxadiazoles; Pyrimidines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Spectrophotometry, Ultraviolet

2003
Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    American journal of respiratory and critical care medicine, 2007, Dec-01, Volume: 176, Issue:11

    Topics: Administration, Inhalation; Aerosols; Animals; Benzoates; Cyclic GMP; Dose-Response Relationship, Drug; Drug Combinations; Guanylate Cyclase; Injections, Intravenous; Lung; Morpholines; Nitric Oxide; Oxadiazoles; Particle Size; Phosphodiesterase Inhibitors; Powders; Pulmonary Circulation; Purinones; Pyrazoles; Pyridines; Pyrimidines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sheep; Soluble Guanylyl Cyclase; Vasodilation

2007
The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 338, Issue:3

    Topics: Animals; Blotting, Western; Cell Line; Cyclic AMP; Cyclic GMP; Enzyme Activators; Enzyme Inhibitors; Glucose; Guanylate Cyclase; Indazoles; Insulin-Secreting Cells; Mitogen-Activated Protein Kinases; Morpholines; Oxadiazoles; Oxazines; Phosphoric Diester Hydrolases; Pyrimidines; Quinoxalines; Rats; Transcription, Genetic

2011
Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus.
    Synapse (New York, N.Y.), 2015, Volume: 69, Issue:10

    Topics: Adenosine; Animals; CA1 Region, Hippocampal; Cadmium Chloride; Colforsin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Long-Term Potentiation; Male; Morpholines; Neurons; Oxadiazoles; Presynaptic Terminals; Pyrimidines; Quinoxalines; Rats; Rats, Wistar

2015